INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,500 | -- | 8,500 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,000 | -- | 500 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 500 | -- | -- |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,626 | -- | -- |
| Sep 28, 2004 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 24,393 | -- | 527,322 |
| Jul 14, 2004 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,000 | $4.00 | 15,391 |
| Jul 14, 2004 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 4,000 | $8.71 | 11,391 |
| Jul 14, 2004 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,000 | $4.00 | 19,391 |
| Jul 14, 2004 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 8,000 | $8.71 | 11,391 |
| Jul 14, 2004 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,000 | $4.00 | 15,391 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.